A 1998 survey by the North American Menopause Society showed that 51% of postmenopausal women reported being happiest and most fulfilled between the ages of 50 and 65 compared with when they were in their 20s (10%), 30s (17%), or 40s (16%). They also reported an interest in healthy activities and in menopause information in order to make informed health decisions.[1]
Women and their physicians now have a variety of screening, assessment, and therapeutic options for preventing and treating postmenopausal osteoporosis. Choosing the most appropriate option is not always easy, and requires not only a basic understanding of recent progress, but also an understanding of the health goals and concerns of each woman.
It is well known and accepted that coronary heart disease (CHD) is the leading cause of death in women.[1] It also contributes a significant burden of morbidity. What still remains unclear is the role that estrogen replacement therapy (ERT) and estrogen with progestin therapy (HRT) have to play in the primary and secondary prevention of this disease complex.
The menopause marks a major life transition for women, an end to the childbearing years and the cessation of the menses. For some it can be an ill-defined concept associated with fear, loss, and sinister connotations, while for others it can be a welcome end to menstruation and the fear of unwanted pregnancy. Many premenopausal women have concerns that they will experience mental instability, sudden signs of aging, and diminution of sexuality at this time.